• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动功能与脑小血管病相关,且可预测死亡率和不良功能结局。

Motor Function Is Associated with Cerebral Small Vessel Disease and Can Predict Mortality and Poor Functional Outcome.

作者信息

Hosoya Megumi, Toi Sono, Seki Misa, Hoshino Takao, Sato Yasuto, Yoshizawa Hiroshi, Iijima Mutsumi, Kitagawa Kazuo

机构信息

Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.

Department of Medicine, Tokyo Women's Medical University, Adachi Medical Center, Tokyo, Japan.

出版信息

Cerebrovasc Dis. 2025;54(4):489-498. doi: 10.1159/000540639. Epub 2024 Sep 16.

DOI:10.1159/000540639
PMID:39284290
Abstract

INTRODUCTION

The primary objective of this study was to elucidate the predictive role of subtle motor impairment evaluated using the Unified Parkinson's Disease Rating Scale (UPDRS) Part III on mortality and functional outcome. The secondary objective was to evaluate the association of motor impairment with small vessel disease (SVD) severity.

METHODS

We derived data from a Japanese cohort of patients with evidence of SVD who were enrolled from 2015 to 2019, and followed until 2023. The present study included 586 participants who agreed for UPDRS Part III evaluation. The severity of white matter hyperintensities (WMHs) and the presence of lacunes were evaluated. Cox proportional hazard models and multiple logistic regression analysis were used to examine the association between UPDRS Part III score and all-cause death and functional outcome defined by the modified Rankin Scale (mRS) score at the last visit, respectively.

RESULTS

The median age was 71 years, and the median UPDRS Part III score was 2. The UPDRS Part III score was associated with the severity of WMH (r = 0.225, p < 0.001) and the number (0, 1, ≥2) of lacunes (p < 0.001). During a mean follow-up period of 4.8 years, 29 patients died. The Cox proportional hazard analysis revealed that high UPDRS Part III scores (≥5) were associated with a higher risk of all-cause death compared to low (score 0) and middle (score 1-4) scores (adjusted hazard ratio 3.04; 95% confidence interval, 1.50-7.34, p = 0.005). In multivariate logistic analysis, high UPDRS Part III scores were associated with poor functional outcome (mRS of ≥3) compared with low and middle scores after adjusting for confounding factors (adjusted odds ratio 1.86; 95% confidence interval 1.02-3.41, p = 0.043).

CONCLUSIONS

Subtle motor impairment was associated with the severity of WMH and number of lacunes and could predict mortality and poor functional outcome independently of vascular risk factors and severity of WMH and lacunes.

摘要

引言

本研究的主要目的是阐明使用统一帕金森病评定量表(UPDRS)第三部分评估的细微运动障碍对死亡率和功能结局的预测作用。次要目的是评估运动障碍与小血管疾病(SVD)严重程度之间的关联。

方法

我们从2015年至2019年入组的有SVD证据的日本患者队列中获取数据,并随访至2023年。本研究纳入了586名同意进行UPDRS第三部分评估的参与者。评估了白质高信号(WMH)的严重程度和腔隙的存在情况。分别使用Cox比例风险模型和多元逻辑回归分析来检验UPDRS第三部分评分与全因死亡以及末次随访时改良Rankin量表(mRS)评分所定义的功能结局之间的关联。

结果

中位年龄为71岁,UPDRS第三部分的中位评分为2分。UPDRS第三部分评分与WMH的严重程度(r = 0.225,p < 0.001)以及腔隙数量(0、1、≥2个)(p < 0.001)相关。在平均4.8年的随访期内,有29名患者死亡。Cox比例风险分析显示,与低(评分为0)和中(评分为1 - 4)评分相比,高UPDRS第三部分评分(≥5)与全因死亡风险更高相关(调整后的风险比为3.04;95%置信区间,1.50 - 7.34,p = 0.005)。在多因素逻辑分析中,在调整混杂因素后,与低评分和中评分相比,高UPDRS第三部分评分与不良功能结局(mRS≥3)相关(调整后的优势比为1.8(6);95%置信区间1.02 - 3.41,p = 0.043)。

结论

细微运动障碍与WMH的严重程度和腔隙数量相关,并且可以独立于血管危险因素以及WMH和腔隙的严重程度来预测死亡率和不良功能结局。

相似文献

1
Motor Function Is Associated with Cerebral Small Vessel Disease and Can Predict Mortality and Poor Functional Outcome.运动功能与脑小血管病相关,且可预测死亡率和不良功能结局。
Cerebrovasc Dis. 2025;54(4):489-498. doi: 10.1159/000540639. Epub 2024 Sep 16.
2
Small vessel disease increases risk of poor outcome through stroke and dementia.小血管疾病通过中风和痴呆增加不良后果的风险。
Hypertens Res. 2025 Jun 4. doi: 10.1038/s41440-025-02242-8.
3
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.抗血栓治疗预防神经影像学检查发现的小血管疾病但无痴呆的患者认知能力下降。
Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds.性别对脑微出血的频率、严重程度和分布的影响。
JAMA Netw Open. 2024 Oct 1;7(10):e2439571. doi: 10.1001/jamanetworkopen.2024.39571.
6
Visit-to-visit blood pressure variability and progression of white matter hyperintensities over 14 years.14 年内访间血压变异性与脑白质高信号进展。
Blood Press. 2024 Dec;33(1):2314498. doi: 10.1080/08037051.2024.2314498. Epub 2024 Mar 13.
7
Genetic Complexities of Cerebral Small Vessel Disease, Blood Pressure, and Dementia.脑小血管病、血压和痴呆的遗传复杂性。
JAMA Netw Open. 2024 May 1;7(5):e2412824. doi: 10.1001/jamanetworkopen.2024.12824.
8
Normative Population-Derived Data for MRI Manifestations of Cerebral Small Vessel Disease.基于人群的脑小血管病 MRI 表现的参考数据。
Stroke. 2024 Dec;55(12):2863-2871. doi: 10.1161/STROKEAHA.124.046731. Epub 2024 Nov 25.
9
Two cases report on the relationship between white matter hyperintensity volume and cognitive dysfunction in cerebral small vessel disease based on magnetic resonance imaging.基于磁共振成像的两例关于脑小血管病中白质高信号体积与认知功能障碍关系的病例报告。
Medicine (Baltimore). 2025 Mar 7;104(10):e41577. doi: 10.1097/MD.0000000000041577.
10
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的体育锻炼:系统评价与网状Meta分析
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.